Proactive Investors - Run By Investors For Investors

Catalyst Biosciences to provide results in one of its hematology trials in 3Q 2019

Catalyst Biosciences (NASDAQ:CBIO) Dr. Nassim Usman spoke with Proactive Investors at the BIO CEO & Investor Conference in New York.

Catalyst is a clinical-stage biopharmaceutical company developing novel medicines to address hematology indications.

 
View full CBIO profile View Profile

Catalyst Biosciences Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use